CDAK
$0.06
Revenue | $0.03Mn |
Net Profits | $-19.28Mn |
Net Profit Margins | -68850% |
CODIAK BIOSCIENCES INC’s revenue fell -97.58% since last year same period to $0.03Mn in the Q3 2022. On a quarterly growth basis, CODIAK BIOSCIENCES INC has generated -99.79% fall in its revenue since last 3-months.
CODIAK BIOSCIENCES INC’s net profit jumped 11.17% since last year same period to $-19.28Mn in the Q3 2022. On a quarterly growth basis, CODIAK BIOSCIENCES INC has generated -184.55% fall in its net profits since last 3-months.
CODIAK BIOSCIENCES INC’s net profit margin fell -3570.6% since last year same period to -68850% in the Q3 2022. On a quarterly growth basis, CODIAK BIOSCIENCES INC has generated -133484.24% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.34 |
EPS Estimate Current Year | -0.34 |
CODIAK BIOSCIENCES INC’s earning per share (EPS) estimates for the current quarter stand at -0.34 - a 58.54% jump from last quarter’s estimates.
CODIAK BIOSCIENCES INC’s earning per share (EPS) estimates for the current year stand at -0.34.
Earning Per Share (EPS) | -0.77 |
CODIAK BIOSCIENCES INC’s earning per share (EPS) jumped 20.62% since last year same period to -0.77 in the Q3 2022. This indicates that the CODIAK BIOSCIENCES INC has generated 20.62% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2022-05-05 | -0.89 | -0.36 | 59.55% |
2022-08-04 | -0.84 | -0.3 | 64.29% |
2022-11-03 | -0.82 | -0.77 | 6.1% |